• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Exalenz Bioscience - Articles and news items

Exalenz Bioscience launches clinical study for breath-based detection of primary liver cancer

Industry news / 4 June 2015 / Victoria White

Exalenz Bioscience has initiated a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +